7-150952457-C-T
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000238.4(KCNH2):c.1525G>A(p.Asp509Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 15/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D509D) has been classified as Likely benign.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | c.1525G>A | p.Asp509Asn | missense_variant | Exon 6 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | c.1525G>A | p.Asp509Asn | missense_variant | Exon 6 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251370 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 40
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome Uncertain:2
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 509 of the KCNH2 protein (p.Asp509Asn). This variant is present in population databases (rs370637245, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of KCNH2-related conditions (PMID: 23631430, 31737537, 34546463). ClinVar contains an entry for this variant (Variation ID: 200354). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces aspartic acid with asparagine at codon 509 of the KCNH2 protein. Computational prediction tools indicate that this variant has a deleterious impact on protein structure and function. This variant is found within a highly conserved pore region (a.a. 404-659). Rare non-truncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in three individuals affected with long QT syndrome (PMID: 34546463, 35911527; ClinVar: SCV000805146.1) and in another individual suspected of having long QT syndrome (PMID: 23631430). This variant has been identified in 1/251370 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Long QT syndrome 2 Pathogenic:1
- -
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Pathogenic:1
PM2_Supporting+PP3_Strong+PS4_Supporting -
not provided Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.D509N variant (also known as c.1525G>A), located in coding exon 6 of the KCNH2 gene, results from a G to A substitution at nucleotide position 1525. The aspartic acid at codon 509 is replaced by asparagine, an amino acid with highly similar properties. This alteration has been reported in arrhythmia genetic testing cohorts (Lieve KV et al. Genet Test Mol Biomarkers, 2013 Jul;17:553-61; Rieder M et al. Front Cardiovasc Med, 2022 Jul;9:916036; Sarquella-Brugada G et al. Hum Genet, 2022 Oct;141:1579-1589). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Cardiac arrhythmia Uncertain:1
This missense variant replaces aspartic acid with asparagine at codon 509 of the KCNH2 protein. Computational prediction tools indicate that this variant has a deleterious impact on protein structure and function. This variant is found within a highly conserved pore region (a.a. 404-659). Rare non-truncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in three individuals affected with long QT syndrome (PMID: 34546463, 35911527; ClinVar: SCV000805146.1) and in another individual suspected of having long QT syndrome (PMID: 23631430). This variant has been identified in 1/251370 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at